Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series

Molecular indicators of colorectal cancer prognosis have been assessed in several studies, but most analyses have been restricted to a handful of markers. We aimed to identify prognostic biomarkers for colorectal cancer by sequencing panels of multiple driver genes.In stage II or III colorectal canc...

Täydet tiedot

Bibliografiset tiedot
Päätekijät:	Domingo, E, Camps, C, Kaisaki, P, Parsons, M, Mouradov, D, Pentony, M, Makino, S, Palmieri, M, Ward, R, Hawkins, N, Gibbs, P, Askautrud, H, Oukrif, D, Wang, H, Wood, J, Tomlinson, E, Bark, Y, Kaur, K, Johnstone, E, Palles, C, Church, D, Novelli, M, Danielsen, H, Sherlock, J, Kerr, D, Kerr, R, Sieber, O, Taylor, J, Tomlinson, I
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	Elsevier 2018

Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series

Samankaltaisia teoksia